| Period Ending: |
LTM
(Last Twelve Months) |
2024 03-31 |
2023 03-31 |
2022 03-31 |
2021 03-31 |
2020 03-31 |
2019 03-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-02-05 | 2024-06-03 | 2023-06-01 | 2022-05-31 | 2021-06-07 | 2020-03-31 | 2019-03-31 |
| Revenue | 490.3 | 490.2 | 535.3 | 507.4 | 378.6 | 224.3 | 191.4 |
| Cost of Revenue | 188.8 | 188 | 227.2 | 225.3 | 152.7 | 88.92 | 84.33 |
| Gross Profit | 301.4 | 302.2 | 308.1 | 282.1 | 225.9 | 135.4 | 107.1 |
| Operating Expenses | 336.4 | 347.7 | 371.9 | 376.3 | 246.5 | 162 | 141.8 |
| Research & Development | 4.7 | 0 | 2.5 | 2.5 | 1.5 | 0 | 0 |
| Selling, General and Administrative | 336.4 | 347.7 | 371.9 | 376.3 | 246.5 | 162 | 141.8 |
| Other Operating Expenses | -4.7 | 0 | -2.5 | -2.5 | -1.5 | 0 | 0 |
| Operating Income | -34.98 | -45.52 | -63.83 | -94.18 | -20.6 | -26.63 | -34.7 |
| Net Non-Operating Interest | 2.92 | 3.18 | 0 | 0 | 0 | 0 | 2.6 |
| Interest Income | 5.69 | 7.53 | 4.37 | 5.46 | 10.92 | 5.42 | 2.6 |
| Interest Expense | 2.78 | 4.35 | 4.37 | 5.46 | 10.92 | 5.42 | 0 |
| Equity & Other Income/(Expense) | 0.356 | 5.33 | 2.31 | 25.88 | -10.79 | -4.74 | -4.98 |
| Income Before Tax | -31.71 | -37.01 | -61.52 | -68.3 | -31.39 | -31.37 | -37.08 |
| Income Tax Expense | -0.643 | 0 | 2.06 | -25.88 | 11.19 | 6 | 0.333 |
| Income Attributable to Non-Controlling Interest | 0.643 | 0 | 0 | 0 | 0 | 0 | -0.333 |
| Net Income | -31.71 | -37.01 | -63.58 | -42.42 | -42.58 | -37.37 | -37.08 |
| Depreciation and Amortization | 6.2 | 12.6 | 14.33 | 8.24 | 2.4 | 1.4 | 0.505 |
| EBITDA | -28.78 | -32.92 | -49.5 | -85.94 | -18.19 | -25.23 | -34.19 |
| Earnings Per Share (EPS) | -0.181 | -0.21 | -0.36 | -0.27 | -1.34 | -0.22 | -7.56 |
| Diluted Earnings Per Share | -0.181 | -0.21 | -0.36 | -0.27 | -1.34 | -0.22 | -7.56 |
| Weighted Average Shares Outstanding | 175.6 | 177.3 | 176.7 | 156.2 | 31.79 | 166.7 | 4.91 |
| Diluted Weighted Average Shares Outstanding | 175.6 | 177.3 | 176.7 | 156.2 | 31.79 | 166.7 | 4.91 |
